Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Dec 28, 2025

Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound
04:35

Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound

Published on: November 21, 2023

944

ESR/ERS statement paper on lung cancer screening.

Hans-Ulrich Kauczor1, Anne-Marie Baird2, Torsten Gerriet Blum3

  • 1Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, German Center of Lung Research, INF 110, 69120, Heidelberg, Germany. hans-ulrich.kauczor@med.uni-heidelberg.de.

European Radiology
|February 14, 2020
PubMed

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Mediastinal Lymph Node Dynamics Associate with Mortality and Fibrosis Progression in Fibrotic ILD.

Chest·2026
Same author

Conservative management of < 3cm anterior mediastinal lesions in lung cancer screening is safe.

European radiology·2026
Same author

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
Same author

Benchmarking of AI and Radiologists for Indeterminate Lung Nodule Malignancy Risk Estimation on Screening CT: The LUNA25 Challenge.

Radiology. Artificial intelligence·2026
Same author

Smoking-Related Comorbidities Detected Through Low-Dose CT Imaging Lung Cancer Screening: Current Evidence and Future Directions.

Chest·2026
Same author

e-Lung computed tomography biomarkers are associated with outcomes in fibrotic interstitial lung diseases.

ERJ open research·2026
Summary

Implementing organized lung cancer screening (LCS) programs in Europe is crucial for early diagnosis and reducing mortality. Key elements include multidisciplinary teams, clear communication, and standardized protocols for high-risk individuals.

Area of Science:

  • Oncology
  • Radiology
  • Public Health

Background:

  • Lung cancer is a leading cause of cancer death in Europe, necessitating improved early detection strategies.
  • Significant advancements and discussions in lung cancer screening (LCS) have emerged since the 2015 joint white paper.
  • Current LCS practices require updates to incorporate new evidence and address practical implementation challenges.

Purpose of the Study:

  • To provide an updated expert opinion on lung cancer screening (LCS) evidence and current European practices.
  • To highlight critical aspects for successful LCS implementation, including participant outreach and shared decision-making.
  • To emphasize the need for standardized infrastructure, quality assurance, and multidisciplinary team involvement.

Main Methods:

Keywords:
Carcinoma, bronchogenicCost-benefit analysisEarly detection of cancerLung neoplasmsTobacco use cessation

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

707
Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules
06:03

Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules

Published on: May 23, 2015

22.7K

Related Experiment Videos

Last Updated: Dec 28, 2025

Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound
04:35

Author Spotlight: Advancing Biopsy Techniques with Transesophageal Ultrasound

Published on: November 21, 2023

944
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

707
Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules
06:03

Use of Electromagnetic Navigational Transthoracic Needle Aspiration E-TTNA for Sampling of Lung Nodules

Published on: May 23, 2015

22.7K
  • A narrative, non-systematic review of evidence from LCS trials.
  • Description of the current practice of LCS in Europe.
  • Analysis of key considerations for LCS implementation, including communication, infrastructure, and quality assurance.

    • Main Results:

    • Effective LCS requires robust infrastructure, clear pathways, and quality assurance, including tobacco cessation support.
    • Multidisciplinary teams involving pulmonologists, radiologists, oncologists, surgeons, pathologists, and family doctors are essential.
    • Standardized algorithms for managing positive screen results and incidental findings are critical for effective LCS.

    Conclusions:

    • European health systems must adapt to support organized LCS pathways to reduce lung cancer mortality.
    • Demonstration programs are needed to focus on methodology, standardization, tobacco cessation, and cost-effectiveness.
    • Targeting high-risk populations using risk prediction models is key to the cost-effectiveness of LCS.